PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Cambridge”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources
PubMed2002

Disease and diversity in history. (Reviews of: Cartwright, FF, Biddiss, M. Disease and history. Gloucestershire: Sutton Publishing Limited, 2000; Rotberg RI, ed. Health and disease in human history. Cambridge, MA: MIT Press, 2000; Cliff, A., Haggett, P., Smallman-Raynor, M. Deciphering global epidemics: analytical approaches to the disease records of world cities, 1888-1912. Cambridge: Cambridge University Press, 1998; Riley, JC. Rising life expectancy: a global history. Cambridge: Cambridge University Press, 2001; McMichael, T. Human frontiers, environments and disease: past patterns, uncertain futures. Cambridge: Cambridge University Press, 2001).

Explore the source record for details and available documents.

Disease↗
PubMed2001

Stereocontrolled Total Synthesis of (+)-Altohyrtin A/Spongistatin 1 Financial support was provided by the EPSRC (GR/L41646), Cambridge Commonwealth Trust (Scholarship to M.J.C.), EC (Marie Curie Postdoctoral Fellowship to J.L.A.), DFG (Postdoctoral Fellowship to T.T.), NSERC-Canada (Postdoctoral Fellowship to R.M.O.), Churchill College (Research Fellowship to D.J.W.), Kingapos;s College and Sims Fund, Cambridge (Scholarship to D.Y.K.C.). We also thank Merck and AstraZeneca Pharmaceuticals for generous support, and Dr. Anne Butlin (AZ) and Dr. Nick Bampos (Cambridge) for valuable assistance.

Explore the source record for details and available documents.

Journal Article↗
PubMed2000

British Pharmacological Society Cambridge Symposia. Pharmacology for the next millennium. 5-7 January 2000, Cambridge, UK.

The Winter Meeting 2000 of the British Pharmacological Society at Cambridge University provided the usual high attendance. This was reflected in the approximately 300 poster and oral communications presented during the course of the 3 days, with a high number contributed by the host institution. The conference comprised three symposia including 'Pharmacology for the next millennium' chaired by Professor Alan Cuthbert, recently retired Head of the Department of Pharmacology in Cambridge. This symposium attracted a prestigious array of internationally renowned speakers, with new information relating to the H3 histamine receptor which has a growing list of potential therapeutic indications. New information regarding screening methodologies, therapeutics for analgesia, schizophrenia and Alzheimer's disease were also reported.

Journal Article↗
PubMed2000

British Pharmacological Society Cambridge Symposia. 5-7 January 2000, Cambridge, UK.

This meeting covered a broad range of pharmacological topics, although the main themes were covered in four mini-symposia. This report concentrates on the cannabinoid, pain and cardiac ischemia symposia. The cannabinoid system was identified as a major area of potential therapeutic interest, offering a number of clinical targets that may be modified through the actions of selective ligands. Novel approaches to the treatment of neurogenic pain, where conventional analgesics have limited value, are being explored with significant success. The role of delayed preconditioning in cardiac ischemia was also addressed as a mechanism of cardioprotection.

Journal Article↗